Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06040762
What this trial is testing

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Who this might be right for
Bladder CancerUrothelial CarcinomaUpper Tract Urothelial Carcinoma+1 more
University of Washington 128
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
Lumara Bio Oncologics GmbH 270
Not applicableNot Yet RecruitingNCT04167332
What this trial is testing

Prospective Collection of Samples for Urothelial Cancer of Bladder

Who this might be right for
Bladder Cancer
Universitaire Ziekenhuizen KU Leuven 630
Not applicableActive Not RecruitingNCT02968732
What this trial is testing

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial Carcinoma
Fox Chase Cancer Center 65
Early research (Phase 1)Looking for participantsNCT05521698
What this trial is testing

Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
University of Wisconsin, Madison 80
Early research (Phase 1)Study completedNCT03854721
What this trial is testing

Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma of the Urinary Bladder
Vaxiion Therapeutics 6
Testing effectiveness (Phase 2)Ended earlyNCT04985604
What this trial is testing

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorCRAF Gene Amplification+20 more
Day One Biopharmaceuticals, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT02527434
What this trial is testing

Study of Tremelimumab in Patients With Advanced Solid Tumors

Who this might be right for
Urothelial Bladder CancerTriple-negative Breast CancerPancreatic Ductal Adenocarcinoma
AstraZeneca 64
Large-scale testing (Phase 3)Study completedNCT00033436
What this trial is testing

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 330
Testing effectiveness (Phase 2)WithdrawnNCT01639521
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

Who this might be right for
Anterior Urethral CancerLocalized Transitional Cell Cancer of the Renal Pelvis and UreterPosterior Urethral Cancer+7 more
University of Southern California
Not applicableNot Yet RecruitingNCT06727214
What this trial is testing

Survival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial Carcinoma
Sara Mahmoud Ahmed Mahmoud 87
Testing effectiveness (Phase 2)UnknownNCT05328336
What this trial is testing

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study

Who this might be right for
Muscle Invasive Bladder Cancer Urothelial Carcinoma
Tianjin Medical University Second Hospital 74
Not applicableLooking for participantsNCT07302230
What this trial is testing

Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial

Who this might be right for
Localized Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of Washington 100
Not applicableStudy completedNCT05902494
What this trial is testing

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Who this might be right for
Urothelial Carcinoma
Seagen, a wholly owned subsidiary of Pfizer 389
Testing effectiveness (Phase 2)Study completedNCT00023842
What this trial is testing

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 97
Large-scale testing (Phase 3)Study completedNCT00028756
What this trial is testing

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

Who this might be right for
Stage III Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder
European Organisation for Research and Treatment of Cancer - EORTC 285
Large-scale testing (Phase 3)UnknownNCT03193788
What this trial is testing

Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy

Who this might be right for
Bladder CancerUreter CancerTransitional Cell Carcinoma
Asan Medical Center 74
Large-scale testing (Phase 3)UnknownNCT00553345
What this trial is testing

Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
University of Birmingham 515
Not applicableStudy completedNCT05070039
What this trial is testing

Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population

Who this might be right for
Urothelial Carcinoma
Sohag University 40
Very early researchActive Not RecruitingNCT07821177
What this trial is testing

Bladder Preservation or Cystectomy for MIBC

Who this might be right for
Muscle-Invasive Bladder CarcinomaBladder CancerUrothelial Carcinoma
Dana-Farber Cancer Institute 20
Next Page